Drug news

EU CHMP recommends extension to indication for Cubicin (daptomycin) to include complicated skin and soft-tissue infections-Cubist Pharma

Read time: 1 mins

Last updated:26th Oct 2015

Published:26th Oct 2015

Source: Pharmawand

The EU's CHMP has recommended adopting an extension to an existing indication for Cubicin (daptomycin) from Cubist Pharma, for treating adults and paediatric (1–17 years) patients with complicated skin and soft-tissue infections (cSSTI). This is an addition to the current indications for adult patients with right-sided infective endocarditis (RIE) due to Staphylococcus aureus, and adults with Staphylococcus aureus bacteraemia (SAB) when associated with RIE or with cSSTI.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Drug news

FDA approves high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm) injection, interchangeable biosimilar to Humira

Boehringer Ingelheim announced that the FDA has approved the high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm), the company’s interchangeable* biosimilar to Humira (adalimumab), to treat multiple chronic inflammatory diseases

1 mins

Drug news

FDA approval for Inceptiv closed-loop spinal cord stimulator stimulator (SCS)for the treatment of chronic pain

Medtronic plc announced that the FDA has approved the Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain

1 min

Drug news

The FDA has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia below-the-knee

Abbott announced that the FDA has approved the Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK)

2 min

See all news